West Announces First-Quarter 2023 Dividend and Participation in Upcoming Investor Conference

West Pharmaceutical Services, Inc. (NYSE: WST) has declared a first-quarter 2023 dividend of $0.19 per share, payable on February 1, 2023, to shareholders of record by January 25, 2023.

Rhea-AI Summary

West Pharmaceutical Services, Inc. (NYSE: WST) has declared a first-quarter 2023 dividend of $0.19 per share, payable on February 1, 2023, to shareholders of record by January 25, 2023. The company reported $2.83 billion in net sales for its fiscal year 2021, highlighting its position as a leader in injectable drug administration solutions. West will also participate in the CJS Securities 23rd Annual "New Ideas for the New Year" Conference on January 11, 2023, at 3:05 pm ET.

Positive

• Dividend of $0.19 per share indicating shareholder returns.
• Strong revenue of $2.83 billion in fiscal year 2021.

Negative

• None.

Argus Session date unavailable

+4.40% session move Open Argus

Details

News Market Reaction – WST

The recorded move for WST in the trading session of this news was +4.40%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

EXTON, Pa., Dec. 13, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announces that the Company's Board of Directors has approved a first-quarter 2023 dividend of $0.19 per share. The dividend will be paid on February 1, 2023, to shareholders of record as of January 25, 2023.

The Company also announces that it will participate in the CJS Securities 23^rd Annual "New Ideas for the New Year" Conference to be held virtually on Wednesday, January 11, 2023, at 3:05 pm ET.

A live audio webcast of the presentation will be available in the "Investors" section of the Company's website at www.westpharma.com. Replay of the webcast will be available for approximately 90 days after the event.

About West  

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With approximately 10,000 team members across 50 sites worldwide, West helps support our customers by delivering over 45 billion components and devices each year.

Headquartered in Exton, Pennsylvania, and in business for nearly a century, West in its fiscal year 2021 generated $2.83 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/west-announces-first-quarter-2023-dividend-and-participation-in-upcoming-investor-conference-301700930.html

SOURCE West Pharmaceutical Services, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the dividend amount for West Pharmaceutical Services (WST) in Q1 2023?

The dividend for Q1 2023 is $0.19 per share.

When will the dividend for West Pharmaceutical Services (WST) be paid?

The dividend will be paid on February 1, 2023.

What is the record date for the dividend payment by West Pharmaceutical Services (WST)?

The record date for the dividend payment is January 25, 2023.

When is West Pharmaceutical Services (WST) participating in the upcoming investor conference?

West will participate in the CJS Securities conference on January 11, 2023, at 3:05 pm ET.